Medtronic (MDT) Chief Accounting Officer Denise Blomquist Receives Awards
$MDT · Medtronic plcResearch Summary
AI-generated summary of this SEC filing
Medtronic (MDT) Chief Accounting Officer Denise Blomquist Receives Awards
What Happened
Denise L. Blomquist, Chief Accounting Officer of Medtronic plc (MDT), had 212 shares withheld to cover taxes on vested restricted stock units (disposed for ~$18,103) and received new equity awards on August 3, 2026. The filing reports a grant of 2,337 shares (no cash price) plus two derivative awards of 2,337 and 1,366 units that are performance- or time-based (no cash price). The withheld shares were a tax-withholding event (routine), while the August 3 entries are equity compensation grants (restricted and performance share units) with future vesting or performance conditions.
Key Details
- Transactions reported: 7/31/2026 — 212 shares withheld at $85.39/share (disposed) = $18,103 (tax withholding). 8/03/2026 — grants/awards: 2,337 shares (acquired, $0), 2,337 derivative units (acquired, $0), and 1,366 derivative units (acquired, $0).
- Vesting/performance notes:
- Restricted stock units (RSUs) vest 100% on the third anniversary of grant (footnote).
- Performance share units (PSUs) are contingent rights to receive shares; performance period ends/conditions referenced April 27, 2029.
- PSU payout is variable: target payout equals 2,337 shares for the referenced PSU; maximum could be up to 5,609 shares if top performance is achieved; minimum may be 0 if performance thresholds are not met.
- 136 shares were acquired via dividend reinvestment since the last report (footnote).
- Shares owned after these transactions not specified in the provided summary.
- Filing date: 2026-08-04. The Form 4 was filed within the standard 2-business-day reporting window for the listed transactions (timely).
Context
Tax-withholding share dispositions are routine and do not indicate a discretionary sale. The August 3 awards are compensation grants: RSUs provide shares at future vesting dates, and PSUs convert to shares only if performance conditions are met (with variable payout). These grants are common executive compensation and should not be interpreted alone as a buy/sell signal.